secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-05-28T23:59:59+00:00
Accession:  0000950170-24-064882
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO O. James Sterling resigns effective May 24; Joel R. Jung appointed interim CFO
--------------------------------------------------------------------------------

- CFO O. James Sterling resigned May 24, 2024; will remain through transition period ending June 10, 2024.
- Board appointed Joel R. Jung as interim CFO effective May 28, 2024; Jung was previously CFO at Minerva Surgical (2020-2024).
- CEO stated company is focused on cost reductions and commercial adoption of KidneyIntelX with FDA approval and reimbursement.
- Resignation did not involve any disagreement with the company; Jung has no material interest in related-party transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024064882/0000950170-24-064882-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024064882/rnlx-20240524.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-064882

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer